Project Grant 1660236

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Teardx, LLC will fund the development of a rapid, point-of-care diagnostic test to accurately detect ocular herpes simplex virus (HSV-1) infections. The project aims to create a user-friendly, minimally invasive sampling tool and assay that can be used by eye specialists and urgent care clinicians to quickly screen for active HSV-1 infections, which are a leading cause...

Federal Grant Award Summary Eye C Better Corp received a $315,825 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), with performance occurring in California from September 1, 2025, through August 31, 2026. The award funds development of a novel non-invasive intraocular pressure (IOP) monitoring technology termed Photonic IOP Biomonitoring (PIB), which measures sound wave-induced scleral oscillations via laser speckle pattern monitoring to enable...

Grant Summary: Next-Generation Brillouin Ocular Scanner Intelon Optics, Inc. received a $566,288 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 15, 2025 through August 31, 2027. The grant funds the development of a next-generation Brillouin Optical Scanner System (BOSS) designed to significantly enhance the speed, accuracy, and sensitivity of ocular biomechanics measurements compared to the existing...

F Square Medical LLC received a $880,668 Project Grant from the National Eye Institute of the National Institutes of Health, Department of Health and Human Services under the Vision Research federal grant program (CFDA 93.867) for the period of September 1, 2021 through August 31, 2022. The funding will support F Square Medical's development of the first-ever safe and effective anterior chamber paracentesis instrument to treat and diagnose ocular diseases. Specifically, the company will refine...

The Ovitz Corporation received a $612,342 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) for the period September 1, 2025 through August 31, 2026. The award funds development of machine learning (ML) tools to automate the design of higher-order aberration (HOA) optics in scleral contact lenses. The project leverages Ovitz's existing Xwave aberrometer system and proprietary algorithm to address current barriers in specialty lens treatment,...

Federal Grant Award Summary Proteris Biotech, Inc. received a $321,904 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) effective August 1, 2025, through July 31, 2026. The award funds Phase I development of Clusterin (CLU), a novel therapeutic targeting epitheliopathy in dry eye disease. The company will conduct early-stage development activities at its Boston incubator facility, including non-Good Manufacturing Practice (GMP) stability...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award, under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $275,000 to Envision Health Technologies Inc. to develop a novel adaptive perimetry software solution for the early detection and monitoring of vision loss due to glaucoma. The project aims to create a fully automated adaptive perimetry test that combines the standardization of static automated perimetry (SAP)...

Federal Grant Award Summary Glaive Medical Optics Inc. received a $304,998 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on October 1, 2025, with completion targeted for September 30, 2026. The awardee will develop a novel implantable intraocular lens device incorporating a low-power, rechargeable visible-light phase shifter and optical phased arrays designed to...

Summary The National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), awarded $417,162 to the University of Houston System for a two-year project (July 1, 2025 – June 30, 2027) investigating the birefringence properties of the lamina cribrosa and posterior eye structures as they relate to glaucoma detection and diagnosis. The project addresses a critical clinical need by developing advanced optical imaging methodologies to detect early structural and stress-related changes...

This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...